FdaApplication
ANDA 212086
Identifiers
- fda_app_no: ANDA212086
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2020-09-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.05MG BASE/ML | INJECTABLE;INJECTION |
1 product